These results show that siRNA@PLGA NPs can efficiently suppress the function of P-glycoproteins in the MDR ovarian cancer cells and thus increase the accumulation of intracellular drugs, which is highly associated with potential tumor responsiveness to chemotherapeutics. The gene discussed is ABCB1; the disease is ovarian carcinoma.